SCHEMBL8768825

SCHEMBL8768825

COc1ccc([C@H]2C[C@@]3(C)[C@@H](C=C[C@@]3(O)CCCO)[C@@H]3CC=C4CC5(CC[C@@H]4[C@H]32)OCCO5)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8767925 0.88 PGR (0.31) —
SCHEMBL8768992 0.87 PGR (0.32) —
SCHEMBL9173750 0.83 NR3C1 (0.35) —
SCHEMBL8767744 0.79 PGR (0.32) —
SCHEMBL9170818 0.77 — —
SCHEMBL8768877 0.77 PARP1 (0.32) —
SCHEMBL8768977 0.77 PARP1 (0.32) —
SCHEMBL8768194 0.76 — —
SCHEMBL8407252 0.76 PGR (0.37) —
SCHEMBL8768115 0.76 PGR (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567469-B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES SCHERING AG (DE) 1997-08-27 — — EP disclosed
US-5426102-A Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties SCHERING AKTIENGESELLSCHAFT (DE) 1995-06-20 — — US disclosed
Send feedback